Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
SOPHiA GENETICS SA stock logo
SOPH
SOPHiA GENETICS
$4.54
-1.5%
$4.86
$2.13
$7.37
$296.14M1.1274,776 shs39,618 shs
SXS
3798 (SXS.V)
C$0.00
C$0.00
C$0.00
N/AN/AN/AN/A
Beginners Guide To Retirement Stocks Cover

Click the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
SOPHiA GENETICS SA stock logo
SOPH
SOPHiA GENETICS
-1.52%-3.20%-6.39%-2.99%+6.82%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
SOPHiA GENETICS SA stock logo
SOPH
SOPHiA GENETICS
1.5539 of 5 stars
3.53.00.00.01.90.00.6
SXS
3798 (SXS.V)
N/AN/AN/AN/AN/AN/AN/AN/A

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
SOPHiA GENETICS SA stock logo
SOPH
SOPHiA GENETICS
3.00
Buy$8.0076.21% Upside
SXS
3798 (SXS.V)
N/AN/AN/AN/A

Current Analyst Ratings

Latest SXS, RSW, SCT, and SOPH Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
3/6/2024
SOPHiA GENETICS SA stock logo
SOPH
SOPHiA GENETICS
BTIG Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$7.00 ➝ $8.00
3/6/2024
SOPHiA GENETICS SA stock logo
SOPH
SOPHiA GENETICS
Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform ➝ Outperform$8.00
(Data available from 5/18/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
SOPHiA GENETICS SA stock logo
SOPH
SOPHiA GENETICS
$62.37M4.75N/AN/A$2.03 per share2.24
SXS
3798 (SXS.V)
N/AN/AN/AN/AN/AN/A

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
SOPHiA GENETICS SA stock logo
SOPH
SOPHiA GENETICS
-$78.98M-$1.12N/AN/AN/A-113.71%-47.56%-35.80%8/13/2024 (Estimated)
SXS
3798 (SXS.V)
N/AN/A0.00N/AN/AN/AN/AN/AN/A

Latest SXS, RSW, SCT, and SOPH Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
3/5/202412/31/2023
SOPHiA GENETICS SA stock logo
SOPH
SOPHiA GENETICS
-$0.25-$0.37-$0.12-$0.37$16.78 million$17.05 million    

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
SOPHiA GENETICS SA stock logo
SOPH
SOPHiA GENETICS
N/AN/AN/AN/AN/A
SXS
3798 (SXS.V)
N/AN/AN/AN/AN/A

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
SOPHiA GENETICS SA stock logo
SOPH
SOPHiA GENETICS
N/A
4.14
3.94
SXS
3798 (SXS.V)
N/AN/AN/A

Ownership

Institutional Ownership

CompanyInstitutional Ownership
SOPHiA GENETICS SA stock logo
SOPH
SOPHiA GENETICS
31.59%
SXS
3798 (SXS.V)
N/A

Insider Ownership

CompanyInsider Ownership
SOPHiA GENETICS SA stock logo
SOPH
SOPHiA GENETICS
4.88%
SXS
3798 (SXS.V)
N/A

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
SOPHiA GENETICS SA stock logo
SOPH
SOPHiA GENETICS
43065.23 million62.05 millionNot Optionable
SXS
3798 (SXS.V)
147,000N/AN/ANot Optionable

SXS, RSW, SCT, and SOPH Headlines

Recent News About These Companies

No headlines for this company have been tracked by MarketBeat.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

SOPHiA GENETICS logo

SOPHiA GENETICS

NASDAQ:SOPH
SOPHiA GENETICS SA operates as a cloud-native software technology company in the healthcare space. The company offers SOPHiA DDM platform, a cloud-native software platform for analyzing data and generating insights from multimodal data sets and diagnostic modalities. Its SOPHiA DDM platform and related solutions, applications, products, and services are used by hospitals, laboratories, and biopharmaceutical companies through its own sales force as well as distributors and industry collaborators in Switzerland, France, Italy, rest of Europe, North America, the United States, Latin America, and the Asia-pacific. SOPHiA GENETICS SA was incorporated in 2011 and is headquartered in Rolle, Switzerland.

3798 (SXS.V)

CVE:SXS
Solimar Energy Limited (Solimar) is an Australia-based oil and gas production and exploration company. The Company has a multi-project asset base focused in the oil prolific San Joaquin Basin, onshore California. The Company's assets are mainly in oil prone trends adjacent giant fields and target both conventional (sandstone) and unconventional (fractured oil shale) reservoirs. Solimar is engaged in conversion of an oil and gas resource potential within its acreage to reserves. The Company operates most of its assets, holding high equity positions. This includes a control position in the Kreyenhagen oil field with significant volumes of oil intersected by numerous wells within the Company's control acreage. The Company's projects include Kreyenhagen, Bayswater, Jacalitos, SELH, Paloma and Tejon Footwall. The Company's subsidiaries include Solimar Australia Energy Pty Ltd and Livingstone Energy Inc.